HALO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Halozyme Therapeutics Inc (HALO) is not a strong buy at this time for a beginner investor with a long-term focus. While the company has shown solid financial growth in its latest quarter, the technical indicators and trading sentiment do not suggest a compelling entry point. Additionally, hedge funds and insiders are selling the stock significantly, and the stock's short-term trend appears weak. Therefore, it is advisable to hold off on buying this stock for now.
The technical indicators show mixed signals. The MACD is positive but contracting, and the RSI is neutral at 47.009. The moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock closed below its pivot point of 77.06, with key support at 72.86. The stock has a 90% chance to decline by -1.32% in the next day and -16.26% in the next month, indicating potential short-term weakness.
Strong financial performance in Q3 2025, with revenue up 22.12% YoY and EPS up 36.19% YoY.
Positive analyst sentiment from TD Cowen, which raised the price target to $90 and maintains a Buy rating.
Hedge funds and insiders are selling the stock significantly, with hedge fund selling up 4215.85% and insider selling up 2642.71%.
Goldman Sachs downgraded the stock to Sell, citing long-term risks to the Enhanze royalty model post-
The stock's short-term trend suggests a potential decline in the coming days and weeks.
Halozyme Therapeutics Inc reported strong financial growth in Q3 2025. Revenue increased by 22.12% YoY to $354.26M, net income rose by 27.89% YoY to $175.23M, and EPS grew by 36.19% YoY to 1.43. Gross margin also improved to 79.39%, up 3.32% YoY.
Analysts have mixed opinions. TD Cowen raised the price target to $90 and maintains a Buy rating, citing strong multi-year growth potential. Morgan Stanley lowered the price target to $75 but maintains an Overweight rating. Goldman Sachs downgraded the stock to Sell with a $56 price target, citing long-term risks to the royalty model.
